CSS
ABEO icon

Cubist Systematic Strategies’s Abeona Therapeutics ABEO Stock Holding History

Cubist Systematic Strategies’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-336
Closed -$25K – 2463
2020
Q2 		$25K Buy
336
+188
+127% +$13K ﹤0.01% 2306
2020
Q1 		$8K Sell
148
-175
-54% -$11.7K ﹤0.01% 2091
2019
Q4 		$26K Buy
+323
New +$22.8K ﹤0.01% 2323
2019
Q3 		– Sell
-1,640
Closed -$196K – 2181
2019
Q2 		$196K Buy
+1,640
New +$275K ﹤0.01% 2059
2019
Q1 		– Sell
-1,935
Closed -$345K – 2214
2018
Q4 		$345K Buy
+1,935
New +$422K 0.02% 1183
2017
Q4 		– Sell
-57
Closed -$25K – 1875
2017
Q3 		$25K Buy
+57
New +$15.3K ﹤0.01% 1768

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's ABEO Position: Q3 2020 in Review

Cubist Systematic Strategies sold out of Abeona Therapeutics (ABEO) in Q3 2020, closing a stake of 336 shares — an estimated $25K sold.

Cubist Systematic Strategies first reported a position in ABEO in Q3 2017 and held it in 6 quarters. The position peaked at $345K in Q4 2018. 78 funds tracked by Wall St. Rank hold ABEO as of Q3 2020.

  • Cubist Systematic Strategies reported no remaining Abeona Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Cubist Systematic Strategies sold 336 Abeona Therapeutics shares in Q3 2020, an estimated $25K.
  • Cubist Systematic Strategies first reported a position in Abeona Therapeutics in Q3 2017 and held it in 6 quarters.
  • Cubist Systematic Strategies's Abeona Therapeutics position peaked at $345K in Q4 2018.
  • 78 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2020.

Based on Cubist Systematic Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.